EBIT: Income before interest and taxes.
Eupraxia Pharmaceuticals Inc. (EPRX) had EBIT of $-18.10M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-15.08M |
|
-- |
|
-- |
|
$18.10M |
|
$-18.10M |
|
$3.64M |
|
$-14.46M |
|
$-14.46M |
|
$-14.49M |
|
$-14.49M |
|
$-14.49M |
|
$-14.49M |
|
|
EBIT |
$-18.10M |
$-17.97M |
|
66.22M |
|
66.22M |
|
$-0.23 |
|
$-0.23 |
|
| Balance Sheet Financials | |
$136.80M |
|
$1.21M |
|
$3.10M |
|
$139.91M |
|
$8.55M |
|
$1.68M |
|
$1.68M |
|
$10.23M |
|
$100.15M |
|
$129.67M |
|
$129.67M |
|
65.47M |
|
| Cash Flow Statement Financials | |
$-23.24M |
|
$-80.22M |
|
$76.06M |
|
$80.56M |
|
$52.43M |
|
$-28.14M |
|
$5.28M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
16.00 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-23.74M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.47% |
|
-11.18% |
|
-10.36% |
|
-11.03% |
|
$1.98 |
|
$-0.36 |
|
$-0.35 |
|